Generic drug makers in countries like India and China are selling substandard medications all over the world, faking data…
Read more
10 minutes to read
Biosimilars are facing the same sort of doctor and patient scepticism that generics met when they were first introduced –…
Read more
The decision of a large player like Apotex to pull three products from the PBS has ramifications for the whole drug supply…
Read more
The Federal Government’s PBS pricing reforms have forced generics company Apotex to delist three preparations, the company…
Read more
The Trans-Pacific Partnership Agreement is likely to increase the cost of medicines and undermine the effectiveness of the…
Read more
Generics approvals questioned The European Medicines Agency (EMA) is recommending suspending approval of a range of…
Read more
Apotex has announced the launch of a new online training portal for pharmacy staff. APOlearn provides pharmacists and…
Read more